Japanese Encephalitis Vaccines Industry Research Report 2025
Description
Summary
According to APO Research, the global Japanese Encephalitis Vaccines market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Japanese Encephalitis Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Japanese Encephalitis Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Japanese Encephalitis Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Japanese Encephalitis Vaccines include Bharat Biotech, Sanofi Pasteur, Valneva Products, GlaxoSmithKline and China National Biotec Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Japanese Encephalitis Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Japanese Encephalitis Vaccines.
The report will help the Japanese Encephalitis Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Japanese Encephalitis Vaccines market size, estimations, and forecasts are provided in terms of sales volume (k doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Japanese Encephalitis Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Japanese Encephalitis Vaccines Segment by Company
Bharat Biotech Sanofi Pasteur Valneva Products GlaxoSmithKline China National Biotec GroupJapanese Encephalitis Vaccines Segment by Type
Attenuated Vaccines Inactivated VaccinesJapanese Encephalitis Vaccines Segment by Application
Adults ChildrenJapanese Encephalitis Vaccines Segment by Region
North America United States Canada Mexico Europe Germany France U.K. Italy Russia Spain Netherlands Switzerland Sweden Poland Asia-Pacific China Japan South Korea India Australia Taiwan Southeast Asia South America Brazil Argentina Chile Middle East & Africa Egypt South Africa Israel Türkiye GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Japanese Encephalitis Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Japanese Encephalitis Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Japanese Encephalitis Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Japanese Encephalitis Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Japanese Encephalitis Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Japanese Encephalitis Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
According to APO Research, the global Japanese Encephalitis Vaccines market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Japanese Encephalitis Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Japanese Encephalitis Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Japanese Encephalitis Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Japanese Encephalitis Vaccines include Bharat Biotech, Sanofi Pasteur, Valneva Products, GlaxoSmithKline and China National Biotec Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Japanese Encephalitis Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Japanese Encephalitis Vaccines.
The report will help the Japanese Encephalitis Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Japanese Encephalitis Vaccines market size, estimations, and forecasts are provided in terms of sales volume (k doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Japanese Encephalitis Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Japanese Encephalitis Vaccines Segment by Company
Bharat Biotech Sanofi Pasteur Valneva Products GlaxoSmithKline China National Biotec GroupJapanese Encephalitis Vaccines Segment by Type
Attenuated Vaccines Inactivated VaccinesJapanese Encephalitis Vaccines Segment by Application
Adults ChildrenJapanese Encephalitis Vaccines Segment by Region
North America United States Canada Mexico Europe Germany France U.K. Italy Russia Spain Netherlands Switzerland Sweden Poland Asia-Pacific China Japan South Korea India Australia Taiwan Southeast Asia South America Brazil Argentina Chile Middle East & Africa Egypt South Africa Israel Türkiye GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Japanese Encephalitis Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Japanese Encephalitis Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Japanese Encephalitis Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Japanese Encephalitis Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Japanese Encephalitis Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Japanese Encephalitis Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Table of Contents
121 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Japanese Encephalitis Vaccines Market Size (2020-2031)
- 2.2.2 Global Japanese Encephalitis Vaccines Sales (2020-2031)
- 2.2.3 Global Japanese Encephalitis Vaccines Market Average Price (2020-2031)
- 2.3 Japanese Encephalitis Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- 2.3.2 Attenuated Vaccines
- 2.3.3 Inactivated Vaccines
- 2.4 Japanese Encephalitis Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.4.2 Adults
- 2.4.3 Children
- 3 Market Competitive Landscape by Manufacturers
- 3.1 Global Japanese Encephalitis Vaccines Market Competitive Situation by Manufacturers (2020 Versus 2024)
- 3.2 Global Japanese Encephalitis Vaccines Sales (k doses) of Manufacturers (2020-2025)
- 3.3 Global Japanese Encephalitis Vaccines Revenue of Manufacturers (2020-2025)
- 3.4 Global Japanese Encephalitis Vaccines Average Price by Manufacturers (2020-2025)
- 3.5 Global Japanese Encephalitis Vaccines Industry Ranking, 2023 VS 2024 VS 2025
- 3.6 Global Manufacturers of Japanese Encephalitis Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Japanese Encephalitis Vaccines, Product Type & Application
- 3.8 Global Manufacturers of Japanese Encephalitis Vaccines, Established Date
- 3.9 Global Japanese Encephalitis Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
- 4 Manufacturers Profiled
- 4.1 Bharat Biotech
- 4.1.1 Bharat Biotech Company Information
- 4.1.2 Bharat Biotech Business Overview
- 4.1.3 Bharat Biotech Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.1.4 Bharat Biotech Japanese Encephalitis Vaccines Product Portfolio
- 4.1.5 Bharat Biotech Recent Developments
- 4.2 Sanofi Pasteur
- 4.2.1 Sanofi Pasteur Company Information
- 4.2.2 Sanofi Pasteur Business Overview
- 4.2.3 Sanofi Pasteur Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.2.4 Sanofi Pasteur Japanese Encephalitis Vaccines Product Portfolio
- 4.2.5 Sanofi Pasteur Recent Developments
- 4.3 Valneva Products
- 4.3.1 Valneva Products Company Information
- 4.3.2 Valneva Products Business Overview
- 4.3.3 Valneva Products Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.3.4 Valneva Products Japanese Encephalitis Vaccines Product Portfolio
- 4.3.5 Valneva Products Recent Developments
- 4.4 GlaxoSmithKline
- 4.4.1 GlaxoSmithKline Company Information
- 4.4.2 GlaxoSmithKline Business Overview
- 4.4.3 GlaxoSmithKline Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.4.4 GlaxoSmithKline Japanese Encephalitis Vaccines Product Portfolio
- 4.4.5 GlaxoSmithKline Recent Developments
- 4.5 China National Biotec Group
- 4.5.1 China National Biotec Group Company Information
- 4.5.2 China National Biotec Group Business Overview
- 4.5.3 China National Biotec Group Japanese Encephalitis Vaccines Sales, Revenue and Gross Margin (2020-2025)
- 4.5.4 China National Biotec Group Japanese Encephalitis Vaccines Product Portfolio
- 4.5.5 China National Biotec Group Recent Developments
- 5 Global Japanese Encephalitis Vaccines Market Scenario by Region
- 5.1 Global Japanese Encephalitis Vaccines Market Size by Region: 2020 VS 2024 VS 2031
- 5.2 Global Japanese Encephalitis Vaccines Sales by Region: 2020-2031
- 5.2.1 Global Japanese Encephalitis Vaccines Sales by Region: 2020-2025
- 5.2.2 Global Japanese Encephalitis Vaccines Sales by Region: 2026-2031
- 5.3 Global Japanese Encephalitis Vaccines Revenue by Region: 2020-2031
- 5.3.1 Global Japanese Encephalitis Vaccines Revenue by Region: 2020-2025
- 5.3.2 Global Japanese Encephalitis Vaccines Revenue by Region: 2026-2031
- 5.4 North America Japanese Encephalitis Vaccines Market Facts & Figures by Country
- 5.4.1 North America Japanese Encephalitis Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.4.2 North America Japanese Encephalitis Vaccines Sales by Country (2020-2031)
- 5.4.3 North America Japanese Encephalitis Vaccines Revenue by Country (2020-2031)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Japanese Encephalitis Vaccines Market Facts & Figures by Country
- 5.5.1 Europe Japanese Encephalitis Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.5.2 Europe Japanese Encephalitis Vaccines Sales by Country (2020-2031)
- 5.5.3 Europe Japanese Encephalitis Vaccines Revenue by Country (2020-2031)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Japanese Encephalitis Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific Japanese Encephalitis Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.6.2 Asia Pacific Japanese Encephalitis Vaccines Sales by Country (2020-2031)
- 5.6.3 Asia Pacific Japanese Encephalitis Vaccines Revenue by Country (2020-2031)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Japanese Encephalitis Vaccines Market Facts & Figures by Country
- 5.7.1 South America Japanese Encephalitis Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.7.2 South America Japanese Encephalitis Vaccines Sales by Country (2020-2031)
- 5.7.3 South America Japanese Encephalitis Vaccines Revenue by Country (2020-2031)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Japanese Encephalitis Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Japanese Encephalitis Vaccines Market Size by Country: 2020 VS 2024 VS 2031
- 5.8.2 Middle East and Africa Japanese Encephalitis Vaccines Sales by Country (2020-2031)
- 5.8.3 Middle East and Africa Japanese Encephalitis Vaccines Revenue by Country (2020-2031)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
- 6 Segment by Type
- 6.1 Global Japanese Encephalitis Vaccines Sales by Type (2020-2031)
- 6.1.1 Global Japanese Encephalitis Vaccines Sales by Type (2020-2031) & (k doses)
- 6.1.2 Global Japanese Encephalitis Vaccines Sales Market Share by Type (2020-2031)
- 6.2 Global Japanese Encephalitis Vaccines Revenue by Type (2020-2031)
- 6.2.1 Global Japanese Encephalitis Vaccines Sales by Type (2020-2031) & (US$ Million)
- 6.2.2 Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2020-2031)
- 6.3 Global Japanese Encephalitis Vaccines Price by Type (2020-2031)
- 7 Segment by Application
- 7.1 Global Japanese Encephalitis Vaccines Sales by Application (2020-2031)
- 7.1.1 Global Japanese Encephalitis Vaccines Sales by Application (2020-2031) & (k doses)
- 7.1.2 Global Japanese Encephalitis Vaccines Sales Market Share by Application (2020-2031)
- 7.2 Global Japanese Encephalitis Vaccines Revenue by Application (2020-2031)
- 7.2.1 Global Japanese Encephalitis Vaccines Sales by Application (2020-2031) & (US$ Million)
- 7.2.2 Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2020-2031)
- 7.3 Global Japanese Encephalitis Vaccines Price by Application (2020-2031)
- 8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Japanese Encephalitis Vaccines Value Chain Analysis
- 8.1.1 Japanese Encephalitis Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Japanese Encephalitis Vaccines Production Mode & Process
- 8.2 Japanese Encephalitis Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Japanese Encephalitis Vaccines Distributors
- 8.2.3 Japanese Encephalitis Vaccines Customers
- 9 Global Japanese Encephalitis Vaccines Analyzing Market Dynamics
- 9.1 Japanese Encephalitis Vaccines Industry Trends
- 9.2 Japanese Encephalitis Vaccines Industry Drivers
- 9.3 Japanese Encephalitis Vaccines Industry Opportunities and Challenges
- 9.4 Japanese Encephalitis Vaccines Industry Restraints
- 10 Report Conclusion
- 11 Disclaimer
- List of Tables
- Table 1. Secondary Sources
- Table 2. Primary Sources
- Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Table 5. Global Japanese Encephalitis Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
- Table 6. Global Japanese Encephalitis Vaccines Sales (k doses) of Manufacturers (2020-2025)
- Table 7. Global Japanese Encephalitis Vaccines Sales Market Share by Manufacturers (2020-2025)
- Table 8. Global Japanese Encephalitis Vaccines Revenue of Manufacturers (2020-2025)
- Table 9. Global Japanese Encephalitis Vaccines Revenue Share by Manufacturers (2020-2025)
- Table 10. Global Market Japanese Encephalitis Vaccines Average Price (US$/dose) of Manufacturers (2020-2025)
- Table 11. Global Japanese Encephalitis Vaccines Industry Ranking, 2023 VS 2024 VS 2025
- Table 12. Global Manufacturers of Japanese Encephalitis Vaccines, Manufacturing Sites & Headquarters
- Table 13. Global Manufacturers of Japanese Encephalitis Vaccines, Product Type & Application
- Table 14. Global Japanese Encephalitis Vaccines Manufacturers Established Date
- Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table 16. Global Japanese Encephalitis Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
- Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
- Table 18. Bharat Biotech Company Information
- Table 19. Bharat Biotech Business Overview
- Table 20. Bharat Biotech Japanese Encephalitis Vaccines Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2020-2025)
- Table 21. Bharat Biotech Japanese Encephalitis Vaccines Product Portfolio
- Table 22. Bharat Biotech Recent Developments
- Table 23. Sanofi Pasteur Company Information
- Table 24. Sanofi Pasteur Business Overview
- Table 25. Sanofi Pasteur Japanese Encephalitis Vaccines Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2020-2025)
- Table 26. Sanofi Pasteur Japanese Encephalitis Vaccines Product Portfolio
- Table 27. Sanofi Pasteur Recent Developments
- Table 28. Valneva Products Company Information
- Table 29. Valneva Products Business Overview
- Table 30. Valneva Products Japanese Encephalitis Vaccines Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2020-2025)
- Table 31. Valneva Products Japanese Encephalitis Vaccines Product Portfolio
- Table 32. Valneva Products Recent Developments
- Table 33. GlaxoSmithKline Company Information
- Table 34. GlaxoSmithKline Business Overview
- Table 35. GlaxoSmithKline Japanese Encephalitis Vaccines Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2020-2025)
- Table 36. GlaxoSmithKline Japanese Encephalitis Vaccines Product Portfolio
- Table 37. GlaxoSmithKline Recent Developments
- Table 38. China National Biotec Group Company Information
- Table 39. China National Biotec Group Business Overview
- Table 40. China National Biotec Group Japanese Encephalitis Vaccines Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2020-2025)
- Table 41. China National Biotec Group Japanese Encephalitis Vaccines Product Portfolio
- Table 42. China National Biotec Group Recent Developments
- Table 43. Global Japanese Encephalitis Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Table 44. Global Japanese Encephalitis Vaccines Sales by Region (2020-2025) & (k doses)
- Table 45. Global Japanese Encephalitis Vaccines Sales Market Share by Region (2020-2025)
- Table 46. Global Japanese Encephalitis Vaccines Sales by Region (2026-2031) & (k doses)
- Table 47. Global Japanese Encephalitis Vaccines Sales Market Share by Region (2026-2031)
- Table 48. Global Japanese Encephalitis Vaccines Revenue by Region (2020-2025) & (US$ Million)
- Table 49. Global Japanese Encephalitis Vaccines Revenue Market Share by Region (2020-2025)
- Table 50. Global Japanese Encephalitis Vaccines Revenue by Region (2026-2031) & (US$ Million)
- Table 51. Global Japanese Encephalitis Vaccines Revenue Market Share by Region (2026-2031)
- Table 52. North America Japanese Encephalitis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 53. North America Japanese Encephalitis Vaccines Sales by Country (2020-2025) & (k doses)
- Table 54. North America Japanese Encephalitis Vaccines Sales by Country (2026-2031) & (k doses)
- Table 55. North America Japanese Encephalitis Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 56. North America Japanese Encephalitis Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 57. Europe Japanese Encephalitis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 58. Europe Japanese Encephalitis Vaccines Sales by Country (2020-2025) & (k doses)
- Table 59. Europe Japanese Encephalitis Vaccines Sales by Country (2026-2031) & (k doses)
- Table 60. Europe Japanese Encephalitis Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 61. Europe Japanese Encephalitis Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 62. Asia Pacific Japanese Encephalitis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 63. Asia Pacific Japanese Encephalitis Vaccines Sales by Country (2020-2025) & (k doses)
- Table 64. Asia Pacific Japanese Encephalitis Vaccines Sales by Country (2026-2031) & (k doses)
- Table 65. Asia Pacific Japanese Encephalitis Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 66. Asia Pacific Japanese Encephalitis Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 67. South America Japanese Encephalitis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 68. South America Japanese Encephalitis Vaccines Sales by Country (2020-2025) & (k doses)
- Table 69. South America Japanese Encephalitis Vaccines Sales by Country (2026-2031) & (k doses)
- Table 70. South America Japanese Encephalitis Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 71. South America Japanese Encephalitis Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 72. Middle East and Africa Japanese Encephalitis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
- Table 73. Middle East and Africa Japanese Encephalitis Vaccines Sales by Country (2020-2025) & (k doses)
- Table 74. Middle East and Africa Japanese Encephalitis Vaccines Sales by Country (2026-2031) & (k doses)
- Table 75. Middle East and Africa Japanese Encephalitis Vaccines Revenue by Country (2020-2025) & (US$ Million)
- Table 76. Middle East and Africa Japanese Encephalitis Vaccines Revenue by Country (2026-2031) & (US$ Million)
- Table 77. Global Japanese Encephalitis Vaccines Sales by Type (2020-2025) & (k doses)
- Table 78. Global Japanese Encephalitis Vaccines Sales by Type (2026-2031) & (k doses)
- Table 79. Global Japanese Encephalitis Vaccines Sales Market Share by Type (2020-2025)
- Table 80. Global Japanese Encephalitis Vaccines Sales Market Share by Type (2026-2031)
- Table 81. Global Japanese Encephalitis Vaccines Revenue by Type (2020-2025) & (US$ Million)
- Table 82. Global Japanese Encephalitis Vaccines Revenue by Type (2026-2031) & (US$ Million)
- Table 83. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2020-2025)
- Table 84. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2026-2031)
- Table 85. Global Japanese Encephalitis Vaccines Price by Type (2020-2025) & (US$/dose)
- Table 86. Global Japanese Encephalitis Vaccines Price by Type (2026-2031) & (US$/dose)
- Table 87. Global Japanese Encephalitis Vaccines Sales by Application (2020-2025) & (k doses)
- Table 88. Global Japanese Encephalitis Vaccines Sales by Application (2026-2031) & (k doses)
- Table 89. Global Japanese Encephalitis Vaccines Sales Market Share by Application (2020-2025)
- Table 90. Global Japanese Encephalitis Vaccines Sales Market Share by Application (2026-2031)
- Table 91. Global Japanese Encephalitis Vaccines Revenue by Application (2020-2025) & (US$ Million)
- Table 92. Global Japanese Encephalitis Vaccines Revenue by Application (2026-2031) & (US$ Million)
- Table 93. Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2020-2025)
- Table 94. Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2026-2031)
- Table 95. Global Japanese Encephalitis Vaccines Price by Application (2020-2025) & (US$/dose)
- Table 96. Global Japanese Encephalitis Vaccines Price by Application (2026-2031) & (US$/dose)
- Table 97. Key Raw Materials
- Table 98. Raw Materials Key Suppliers
- Table 99. Japanese Encephalitis Vaccines Distributors List
- Table 100. Japanese Encephalitis Vaccines Customers List
- Table 101. Japanese Encephalitis Vaccines Industry Trends
- Table 102. Japanese Encephalitis Vaccines Industry Drivers
- Table 103. Japanese Encephalitis Vaccines Industry Restraints
- Table 104. Authors List of This Report
- List of Figures
- Figure 1. Research Methodology
- Figure 2. Research Process
- Figure 3. Key Executives Interviewed
- Figure 4. Japanese Encephalitis Vaccines Product Image
- Figure 5. Global Japanese Encephalitis Vaccines Revenue (US$ Million), 2020 VS 2024 VS 2031
- Figure 6. Global Japanese Encephalitis Vaccines Market Size (2020-2031) & (US$ Million)
- Figure 7. Global Japanese Encephalitis Vaccines Sales (2020-2031) & (k doses)
- Figure 8. Global Japanese Encephalitis Vaccines Average Price (US$/dose) & (2020-2031)
- Figure 9. Attenuated Vaccines Product Image
- Figure 10. Inactivated Vaccines Product Image
- Figure 11. Adults Product Image
- Figure 12. Children Product Image
- Figure 13. Global Japanese Encephalitis Vaccines Revenue Share by Manufacturers in 2024
- Figure 14. Global Manufacturers of Japanese Encephalitis Vaccines, Manufacturing Sites & Headquarters
- Figure 15. Global Top 5 and 10 Japanese Encephalitis Vaccines Players Market Share by Revenue in 2024
- Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 17. Global Japanese Encephalitis Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
- Figure 18. Global Japanese Encephalitis Vaccines Sales by Region in 2024
- Figure 19. Global Japanese Encephalitis Vaccines Revenue by Region in 2024
- Figure 20. North America Japanese Encephalitis Vaccines Market Size by Country in 2024
- Figure 21. North America Japanese Encephalitis Vaccines Sales Market Share by Country (2020-2031)
- Figure 22. North America Japanese Encephalitis Vaccines Revenue Market Share by Country (2020-2031)
- Figure 23. United States Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 24. Canada Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 25. Mexico Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 26. Europe Japanese Encephalitis Vaccines Market Size by Country in 2024
- Figure 27. Europe Japanese Encephalitis Vaccines Sales Market Share by Country (2020-2031)
- Figure 28. Europe Japanese Encephalitis Vaccines Revenue Market Share by Country (2020-2031)
- Figure 29. Germany Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 30. France Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 31. U.K. Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 32. Italy Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 33. Russia Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 34. Spain Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 35. Netherlands Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 36. Switzerland Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 37. Sweden Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 38. Poland Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 39. Asia Pacific Japanese Encephalitis Vaccines Market Size by Country in 2024
- Figure 40. Asia Pacific Japanese Encephalitis Vaccines Sales Market Share by Country (2020-2031)
- Figure 41. Asia Pacific Japanese Encephalitis Vaccines Revenue Market Share by Country (2020-2031)
- Figure 42. China Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 43. Japan Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 44. South Korea Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 45. India Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 46. Australia Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 47. Taiwan Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 48. Southeast Asia Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 49. Southeast Asia Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 50. South America Japanese Encephalitis Vaccines Market Size by Country in 2024
- Figure 51. South America Japanese Encephalitis Vaccines Sales Market Share by Country (2020-2031)
- Figure 52. South America Japanese Encephalitis Vaccines Revenue Market Share by Country (2020-2031)
- Figure 53. Brazil Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 54. Argentina Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 55. Chile Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 56. Middle East and Africa Japanese Encephalitis Vaccines Market Size by Country in 2024
- Figure 57. Middle East and Africa Japanese Encephalitis Vaccines Sales Market Share by Country (2020-2031)
- Figure 58. Middle East and Africa Japanese Encephalitis Vaccines Revenue Market Share by Country (2020-2031)
- Figure 59. Egypt Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 60. South Africa Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 61. Israel Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 62. Türkiye Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 63. GCC Countries Japanese Encephalitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
- Figure 64. Global Japanese Encephalitis Vaccines Sales Market Share by Type (2020-2031)
- Figure 65. Global Japanese Encephalitis Vaccines Revenue Market Share by Type (2020-2031)
- Figure 66. Global Japanese Encephalitis Vaccines Price (US$/dose) by Type (2020-2031)
- Figure 67. Global Japanese Encephalitis Vaccines Sales Market Share by Application (2020-2031)
- Figure 68. Global Japanese Encephalitis Vaccines Revenue Market Share by Application (2020-2031)
- Figure 69. Global Japanese Encephalitis Vaccines Price (US$/dose) by Application (2020-2031)
- Figure 70. Japanese Encephalitis Vaccines Value Chain
- Figure 71. Japanese Encephalitis Vaccines Production Mode & Process
- Figure 72. Direct Comparison with Distribution Share
- Figure 73. Distributors Profiles
- Figure 74. Japanese Encephalitis Vaccines Industry Opportunities and Challenges
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
